Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease. Applied Biomarkers in Late Effects (ABLE) (ABLE3.0/CTTC2201)

NCT05692713 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT05692713
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05692713 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease. Applied Biomarkers in Late Effects (ABLE) (ABLE3.0/CTTC2201)
Lead sponsor
University of British Columbia
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2023
Completion date
June 30, 2025
Enrollment
320 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

allogeneic hematopoietic stem cell transplantation, blood cancer, chronic graft-versus-host-disease, leukemia, non-malignant hematologic and lymphocytic disorder